Welcome
Support Centre
11 February 2012 
Current Controlled Trials - Clinical Trials
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   news
Introduction
English introduction Introduction en français Deutsche einleitung
Introducción española Introduzione in italiano
 
Find trials
active registers
mental health register
archived registers
all registers
tips on searching
 
 
Information
about mRCT
mRCT FAQs

DISCLAIMER
The site should not be used to diagnose or treat a health problem. Please consult your doctor.
Terms & conditions

DUPLICATION
Your search result may contain a number of different records for the same trial. This occurs when the same trial is listed in more than one register.

[ ...Back to search results ] [ Print-friendly version ]
Randomised controlled trial of bezafibrate in patients with lower extremity arterial disease (LEAD)
Source of recordUK Trials
ISRCTNISRCTN41194621
Date ISRCTN assigned06/04/2000
Local reference number(s)E185/124
Public titleRandomised controlled trial of bezafibrate in patients with lower extremity arterial disease (LEAD)
Scientific title
AcronymLEADER trial
Disease/condition/study domainCardiovascular
Study hypothesisBezafibrate reduces primary end point by 30%.
Design/methodologyRandomised controlled trial
Research ethics reviewNot provided at time of registration
Countries of trialUnited Kingdom
Participants - inclusion criteriaMales with LEAD (no upper or lower age limit)
Participants - exclusion criteria1. Already on lipid-modifying agent
2. Renal or hepatic disease (including raised creatinine concentration)
3. Unstable angina; malignant disease
4. Serious intercurrent illness
Patient information material
Anticipated start date01/05/1992
Anticipated end date30/09/2001
Status of trialCompleted
Target number of participants1568 men recruited through 85 practices in the Medical Research
InterventionsBezafibrate/control
Primary outcome measure(s)Coronary heart disease events and strokes combined
Secondary outcome measure(s)Fatal and non-fatal coronary events separately
PublicationsT.W. Meade for the British Medical Council General Practive Research Framework and participating vascular clinics. Design and intermediate results of the Lower Extremity Arterial Disease Event Reduction (LEADER) trial of bezafibrate in men with lower extremity arterial disease. [ISRCTN4119421] Curr Control Trials Cardiovasc Med, 2001;2:195-204.

T.W. Meade, R. Zuhrie, C. Cook, J. Cooper. Bezafibrate in men with lower extremity arterial disease: randomised controlled trial. [ISRCTN4119421] BMJ, 2002;325:1139-1141.
Sources of fundingMedical Research Council (UK)
Sponsor nameMedical Research Council (UK)
Sponsor details20 Park Crescent
London
United Kingdom
W1B 1AL
Sponsor telephone+44 (0)20 7636 5422
Sponsor fax+44 (0)20 7436 6179
Sponsor emailclinical.trial@headoffice.mrc.ac.uk
Sponsor websitehttp://www.mrc.ac.uk
Contact nameProf TW Meade
Contact detailsNon-communicable Disease Epidemiology Unit
Department of Epidemiology and Population Health
London School of Hygiene and Tropical Medicine
Keppel Street
London
United Kingdom
WC1E 7HT
Contact telephone+44 (0)20 7927 2182
Contact fax+44 (0)20 7580 6897
Contact emailtom.meade@lshtm.ac.uk
More informationFor more up-to-date information please go to the ISRCTN link below.
Link to record in ISRCTN RegisterISRCTN41194621
Date last extracted from ISRCTN register17/04/2008
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 Current Controlled Trials Ltd. Part of Springer Science+Business Media. | terms & conditions | privacy statement


BioMed Central